INFUSYSTEM HOLDINGS, INC Increase (Decrease) in Accounts Payable and Other Operating Liabilities
INFUSYSTEM HOLDINGS, INC (INFU) reported Increase (Decrease) in Accounts Payable and Other Operating Liabilities of -$2.60 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-06-30 was $725.00K.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2026-03-31 was -$3.33M.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-12-31 was -$575.00K, a 203.98% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for the quarter ending 2025-09-30 was $1.84M, a 9.53% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for fiscal 2025 was -$708.00K.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for fiscal 2024 was -$676.00K, a 127.99% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for fiscal 2023 was $2.42M, a 17.91% decline from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC increase (decrease) in accounts payable and other operating liabilities for fiscal 2022 was $2.94M.
| Period end | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 3 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 6 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 9 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month | Increase (Decrease) in Accounts Payable and Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$2.60M 10-Q · filed 2026-08-04 | -$3.18M derived: sum of 3 quarters · filed 2026-08-04 | -$1.34M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | -$3.33M 10-Q · filed 2026-05-08 | -$3.90M derived: sum of 2 quarters · filed 2026-05-08 | -$2.06M derived: sum of 3 quarters · filed 2026-05-08 | -$2.46M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | -$575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.27M derived: sum of 2 quarters · filed 2026-02-27 | $869.00K derived: sum of 3 quarters · filed 2026-08-04 | -$708.00K 10-K · filed 2026-02-27 | |
| 2025-09-30 | $1.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $1.44M derived: sum of 2 quarters · filed 2026-08-04 | -$133.00K 10-Q · filed 2025-11-04 | $420.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | -$398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$1.98M 10-Q · filed 2026-08-04 | -$1.42M derived: sum of 3 quarters · filed 2026-08-04 | $614.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$1.58M 10-Q · filed 2026-05-08 | -$1.02M derived: sum of 2 quarters · filed 2026-05-08 | $1.01M derived: sum of 3 quarters · filed 2026-05-08 | -$1.15M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $553.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.59M derived: sum of 2 quarters · filed 2026-02-27 | $430.00K derived: sum of 3 quarters · filed 2026-02-27 | -$676.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$123.00K derived: sum of 2 quarters · filed 2025-11-04 | -$1.23M 10-Q · filed 2025-11-04 | $1.48M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | -$2.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$3.27M 10-Q · filed 2025-08-05 | -$561.00K derived: sum of 3 quarters · filed 2025-08-05 | $333.00K derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | -$1.11M 10-Q · filed 2025-05-08 | $1.60M derived: sum of 2 quarters · filed 2025-05-08 | $2.49M derived: sum of 3 quarters · filed 2025-05-08 | $996.00K derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $3.60M derived: sum of 2 quarters · filed 2025-03-11 | $2.10M derived: sum of 3 quarters · filed 2025-03-11 | $2.42M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $894.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$602.00K derived: sum of 2 quarters · filed 2024-11-08 | -$289.00K 10-Q · filed 2024-11-08 | $1.45M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.18M 10-Q · filed 2024-08-09 | $559.00K derived: sum of 3 quarters · filed 2024-08-09 | -$737.00K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $313.00K 10-Q · filed 2024-05-09 | $2.06M derived: sum of 2 quarters · filed 2024-05-09 | $759.00K derived: sum of 3 quarters · filed 2024-05-09 | $1.61M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $446.00K derived: sum of 2 quarters · filed 2024-04-10 | $1.30M derived: sum of 3 quarters · filed 2024-04-10 | $2.94M 10-K · filed 2024-04-10 | |
| 2022-09-30 | -$1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$441.00K derived: sum of 2 quarters · filed 2023-11-09 | $1.20M 10-Q · filed 2023-11-09 | -$650.00K derived: sum of 4 quarters · filed 2024-04-10 | |
| 2022-06-30 | $855.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $2.50M 10-Q · filed 2023-08-09 | $646.00K derived: sum of 3 quarters · filed 2024-04-10 | $1.74M derived: sum of 4 quarters · filed 2024-04-10 | |
| 2022-03-31 | $1.64M 10-Q · filed 2023-05-09 | -$209.00K derived: sum of 2 quarters · filed 2024-04-10 | $885.00K derived: sum of 3 quarters · filed 2024-04-10 | $2.17M derived: sum of 4 quarters · filed 2024-04-10 | |
| 2021-12-31 | -$1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | -$756.00K derived: sum of 2 quarters · filed 2024-04-10 | $526.00K derived: sum of 3 quarters · filed 2024-04-10 | -$2.36M 10-K · filed 2024-04-10 | |
| 2021-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.38M derived: sum of 2 quarters · filed 2022-11-08 | -$513.00K 10-Q · filed 2022-11-08 | $2.75M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$1.61M 10-Q · filed 2022-08-04 | $1.66M derived: sum of 3 quarters · filed 2023-03-16 | $1.74M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-03-31 | -$2.89M 10-Q · filed 2022-05-05 | $374.00K derived: sum of 2 quarters · filed 2023-03-16 | $461.00K derived: sum of 3 quarters · filed 2023-03-16 | -$1.92M derived: sum of 4 quarters · filed 2023-03-16 | |
| 2020-12-31 | $3.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.35M derived: sum of 2 quarters · filed 2023-03-16 | $971.00K derived: sum of 3 quarters · filed 2023-03-16 | $2.39M 10-K · filed 2023-03-16 | |
| 2020-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$2.29M derived: sum of 2 quarters · filed 2021-11-15 | -$869.00K 10-Q · filed 2021-11-15 | -$185.00K derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | -$2.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$956.00K 10-Q · filed 2021-08-12 | -$272.00K derived: sum of 3 quarters · filed 2022-03-15 | $1.12M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | $1.42M 10-Q · filed 2021-05-10 | $2.11M derived: sum of 2 quarters · filed 2022-03-15 | $3.50M derived: sum of 3 quarters · filed 2022-03-15 | ||
| 2019-12-31 | $684.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.07M derived: sum of 2 quarters · filed 2022-03-15 | $2.44M 10-K · filed 2022-03-15 | ||
| 2019-09-30 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.75M 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $364.00K 10-Q · filed 2020-08-14 | ||||
| 2018-12-31 | $183.00K 10-K · filed 2020-03-30 | ||||
| 2017-12-31 | -$352.00K 10-K · filed 2019-03-22 | ||||
| 2016-12-31 | -$3.15M 10-K · filed 2018-03-19 | ||||
| 2015-12-31 | -$2.78M 10-K · filed 2017-03-22 | ||||
| 2014-12-31 | -$4.03M 10-K/A · filed 2016-12-12 | ||||
| 2013-12-31 | -$1.08M 10-K · filed 2015-03-09 | ||||
| 2012-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$1.42M derived: sum of 2 quarters · filed 2014-03-11 | -$186.00K derived: sum of 3 quarters · filed 2014-03-11 | -$335.00K 10-K · filed 2014-03-11 | |
| 2012-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $2.52M derived: sum of 2 quarters · filed 2012-11-14 | $2.37M 10-Q · filed 2012-11-14 | $5.58M derived: sum of 4 quarters · filed 2013-03-28 | |
| 2012-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $1.08M 10-Q · filed 2012-08-08 | $4.29M derived: sum of 3 quarters · filed 2013-03-28 | $2.20M derived: sum of 4 quarters · filed 2013-03-28 | |
| 2012-03-31 | -$149.00K 10-Q · filed 2012-05-21 | $3.06M derived: sum of 2 quarters · filed 2013-03-28 | $970.00K derived: sum of 3 quarters · filed 2013-03-28 | -$1.53M derived: sum of 4 quarters · filed 2013-03-28 | |
| 2011-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.12M derived: sum of 2 quarters · filed 2013-03-28 | -$1.38M derived: sum of 3 quarters · filed 2013-03-28 | -$1.53M 10-K · filed 2013-03-28 | -$3.97M 10-K · filed 2012-03-16 |
| 2011-09-30 | -$2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | -$4.59M derived: sum of 2 quarters · filed 2012-11-14 | -$4.74M 10-Q · filed 2012-11-14 | -$3.04M derived: sum of 4 quarters · filed 2012-11-14 | |
| 2011-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$2.65M 10-Q · filed 2012-08-08 | -$952.00K derived: sum of 3 quarters · filed 2012-08-08 | -$1.56M derived: sum of 4 quarters · filed 2012-08-08 | |
| 2011-03-31 | -$152.00K 10-Q · filed 2012-05-21 | $1.55M derived: sum of 2 quarters · filed 2012-05-21 | $935.00K derived: sum of 3 quarters · filed 2012-05-21 | ||
| 2010-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $1.09M derived: sum of 2 quarters · filed 2012-03-16 | $2.25M 10-K · filed 2012-03-16 | ||
| 2010-09-30 | -$612.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $553.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | $1.17M 10-Q · filed 2011-08-15 | ||||
| 2009-12-31 | $872.00K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |